Clinical Trial Update: Effects of tDCS on Apraxia of Speech in Non-Fluent Primary Progressive Aphasia [NA]

View source ↗

Summary

A clinical trial evaluating transcranial direct current stimulation (tDCS) for apraxia of speech in non-fluent primary progressive aphasia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Aphasia

Snippet

Sponsor: Johns Hopkins University | Conditions: Primary Progressive Aphasia | NA | Status: WITHDRAWN